我武生物10月20日获融资买入9796.48万元，融资余额4.35亿元

Group 1 - The core viewpoint of the news highlights the significant trading activity and financial performance of Iwu Biotech, with a notable increase in stock price and trading volume on October 20, 2023 [1] - On October 20, Iwu Biotech's stock rose by 10.07%, with a trading volume of 737 million yuan, and a net financing purchase of 28.68 million yuan [1] - As of October 20, the total margin balance for Iwu Biotech was 438 million yuan, with a financing balance of 435 million yuan, representing 2.53% of the circulating market value [1] Group 2 - For the first half of 2025, Iwu Biotech reported a revenue of 484 million yuan, reflecting a year-on-year growth of 12.81%, and a net profit attributable to shareholders of 177 million yuan, up 18.61% [2] - The company has distributed a total of 913 million yuan in dividends since its A-share listing, with 317 million yuan distributed in the last three years [3] - As of June 30, 2025, the number of shareholders for Iwu Biotech was 34,600, a decrease of 3.53% from the previous period, while the average circulating shares per person increased by 3.66% to 13,999 shares [2]